Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 245

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Peptic ulcer disease and non-steroidal anti-inflammatory drugs

Open access
Drina, Musa · 2017 · Australian Prescriber

Abstract

Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines.They are associated with gastrointestinal mucosal injury.Before prescribing, it is important to assess the patient's gastrointestinal risk factors such as age and history of peptic ulcers.Patients at high risk may require co-prescription to reduce the risk of peptic ulcers.A daily dose of a proton pump inhibitor is the most effective method of reducing the risk of ulcers induced by non-steroidal anti-inflammatory drugs.in gastric mucosa.This therefore increases the susceptibility to mucosal injury.6 Inhibition of COX-2 may also play a role in mucosal injury. Risk factorsGastrointestinal toxicity with NSAIDs, including low-dose aspirin, is highest in patients with risk factors.These include increased age (>65 years), past history of peptic ulcer disease, heart disease, and co-prescription of antiplatelets, corticosteroids and anticoagulants.In addition, using higher doses of NSAIDs leads to an increased risk of upper gastrointestinal complications.7 Prolonged NSAID use and H. pylori infection are also associated with an increased risk of gastrointestinal toxicity.In patients who are chronic users of NSAIDs and who have no risk factors, only 0.4% have serious adverse events.However, the risk is as high as 9% in patients with multiple risk factors.8 Before prescribing for a patient with risk factors always consider if there are alternatives to NSAIDs. Which NSAID to use?All NSAIDs cause some degree of gastrointestinal toxicity.Large pooled data from placebo-controlled trials show that all evaluated NSAIDs including COX-2 inhibitors, diclofenac, ibuprofen and naproxen were associated with an increased risk of gastrointestinal injury.9 However, this risk varies between the drugs.The relative risk of upper gastrointestinal complications for aceclofenac, celecoxib and ibuprofen is low (<2).Diclofenac, meloxicam and ketoprofen are intermediate (2-4) while naproxen, indomethacin and diflunisal have a higher relative risk (4-5).The highest pooled relative risk is associated with piroxicam (7.4) and ketorolac (11.5).7

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18773/austprescr.2017.037

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 245

Metadata

Authors
Drina, M.
Venue
Australian Prescriber
Published
2017-06-01
Volume
40
Issue
3
Pages
91-93
ISSN
  • 0312-8008 (ISSN-L)
  • 1839-3942
OpenAlex
W2618677665
Cited by
245
References
1
FWCI
9.65
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Peptic ulcer disease and non-steroidal anti-inflammatory drugs. https://app.cochat.ai/papers/10.18773/austprescr.2017.037
The paper
Drina, M. (2017). Peptic ulcer disease and non-steroidal anti-inflammatory drugs. Australian Prescriber. https://doi.org/10.18773/austprescr.2017.037

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.